NPI: 1083031223 · LAKE MARY, FL 32746 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/26/2014
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/26/2014 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 335 | $28K |
| 2019 | 5,906 | $803K |
| 2020 | 10,303 | $1.37M |
| 2021 | 6,735 | $579K |
| 2022 | 6,123 | $1.01M |
| 2023 | 4,698 | $351K |
| 2024 | 2,024 | $80K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 17,510 | 1,043 | $1.90M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 12,245 | 563 | $1.64M |
| J1756 | Injection, iron sucrose, 1 mg | 2,562 | 450 | $186K |
| A4657 | Syringe, with or without needle, each | 976 | 516 | $185K |
| 85048 | 703 | 378 | $69K | |
| 85041 | 701 | 378 | $69K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 196 | 13 | $60K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 152 | 54 | $26K |
| 83970 | 221 | 124 | $22K | |
| 82728 | 242 | 128 | $22K | |
| 83540 | 245 | 127 | $20K | |
| 83550 | 245 | 127 | $20K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 60 | 26 | $3K |
| 82108 | 22 | 12 | $441.98 | |
| 82746 | 22 | 12 | $441.98 | |
| 82607 | 22 | 12 | $441.98 |